A Review on Nanoparticles Drug Delivery System
Abstract
The method or process of delivering a pharmaceutical ingredient to create a therapeutic effect in people or animals is referred to as drug delivery. Nasal and pulmonary routes of medication administration are becoming increasingly important in the treatment of human illnesses. These methods, especially for peptide and protein therapies, provide potential alternatives to parenteral drug administration. Several medication delivery methods have been developed for this purpose and are being tested for nasal and pulmonary delivery. Chitosan, Alginate, vanilline oxalate, zinc oxalate, cellulose, polymeric micelles, Gliadin, and phospholipid are examples of these. Multidrug resistance, a key issue in chemotherapy, can be reversed with these nanoparticles. Surgery, chemotherapy, immunotherapy, and radiation are all well-established treatments used in cancer treatment. A nanoparticle has emerged as a potential method for the targeted delivery of medicines used to treat certain illnesses.
Keywords: Nasal Drug Delivery, Pulmonary Drug Delivery, Nanoparticles
Keywords:
Nasal Drug Delivery, Pulmonary Drug Delivery, NanoparticlesDOI
https://doi.org/10.22270/jddt.v11i4.4865References
Jahanshahi M, Babaei Z. Protein nanoparticle: a unique system as drug delivery vehicles. African Journal of Biotechnology. 2008 ;7(25).
Xin Y, Huang Q, Tang JQ, Hou XY, Zhang P, Zhang LZ, Jiang G. Nanoscale drug delivery for targeted chemotherapy. Cancer letters. 2016 Aug 28; 379(1):24-31. https://doi.org/10.1016/j.canlet.2016.05.023
Muhamad12 II, Selvakumaran S, Lazim NA. Designing polymeric nanoparticles for targeted drug delivery system. Nanomed. 2014; 287:287.
Parveen S, Misra R, Sahoo SK. Nanoparticles: a boon to drug delivery, therapeutics, diagnostics and imaging. Nanomedicine: Nanotechnology, Biology and Medicine. 2012 Feb 1; 8(2):147-66. https://doi.org/10.1016/j.nano.2011.05.016
Kwon J, Kim J, Park S, Khang G, Kang PM, Lee D. Inflammation-responsive antioxidant nanoparticles based on a polymeric prodrug of vanillin. Biomacromolecules. 2013 May 13; 14(5):1618-26. https://doi.org/10.1021/bm400256h
Park H, Kim S, Kim S, Song Y, Seung K, Hong D, Khang G, Lee D. Antioxidant and anti-inflammatory activities of hydroxybenzyl alcohol releasing biodegradable polyoxalate nanoparticles. Biomacromolecules. 2010 Aug 9; 11(8):2103-8. https://doi.org/10.1021/bm100474w
Ricchetti ME. Oxidative Stress Reduction, Redox Homeostasis & Antioxidants.
Swami Vetha BS, Adam AG, Aileru A. Redox Responsive Copolyoxalate Smart Polymers for Inflammation and Other Aging-Associated Diseases. International Journal of Molecular Sciences. 2021 Jan; 22(11):5607. https://doi.org/10.3390/ijms22115607
Konat Zorzi G, Contreras-Ruiz L, Párraga JE, López-García A, Romero Bello R, Diebold Y, Seijo B, Sánchez A. Expression of MUC5AC in ocular surface epithelial cells using cationized gelatin nanoparticles. Molecular pharmaceutics. 2011 Oct 3; 8(5):1783-8. https://doi.org/10.1021/mp200155t
Alonso MJ, Sánchez A. The potential of chitosan in ocular drug delivery. Journal of pharmacy and pharmacology. 2003 Nov;5 5(11):1451-63. https://doi.org/10.1211/0022357022476
Pandit J, Sultana Y, Aqil M. Chitosan-coated PLGA nanoparticles of bevacizumab as novel drug delivery to target retina: optimization, characterization, and in vitro toxicity evaluation. Artificial cells, nanomedicine, and biotechnology. 2017 Oct 3; 45(7):1397-407. https://doi.org/10.1080/21691401.2016.1243545
Sun SB, Liu P, Shao FM, Miao QL. Formulation and evaluation of PLGA nanoparticles loaded capecitabine for prostate cancer. International journal of clinical and experimental medicine. 2015; 8(10):19670.
Hossen S, Hossain MK, Basher MK, Mia MN, Rahman MT, Uddin MJ. Smart nanocarrier-based drug delivery systems for cancer therapy and toxicity studies: A review. Journal of advanced research. 2019 Jan 1; 15:1-8. https://doi.org/10.1016/j.jare.2018.06.005
Kumar SU, Matai I, Dubey P, Bhushan B, Sachdev A, Gopinath P. Differentially cross-linkable core-shell nanofibers for tunable delivery of anticancer drugs: synthesis, characterization and their anticancer efficacy. RSC advances. 2014; 4(72):38263-72. https://doi.org/10.1039/C4RA05001K
Lee WH, Loo CY, Young PM, Traini D, Mason RS, Rohanizadeh R. Recent advances in curcumin nanoformulation for cancer therapy. Expert opinion on drug delivery. 2014 Aug 1; 11(8):1183-201. https://doi.org/10.1517/17425247.2014.916686
Mannava MK, Suresh K, Kumar Bommaka M, Bhavani Konga D, Nangia A. Curcumin-artemisinin coamorphous solid: Xenograft model preclinical study. Pharmaceutics. 2018 Mar; 10(1):7. https://doi.org/10.3390/pharmaceutics10010007
Mehanna MM, Mohyeldin SM, Elgindy NA. Respirable nanocarriers as a promising strategy for antitubercular drug delivery. Journal of controlled release. 2014 Aug 10; 187:183-97. https://doi.org/10.1016/j.jconrel.2014.05.038
Patel S, Freedman S, Chapman KL, Emms F, Fletcher AE, Knowles M, Marwood R, Mcallister G, Myers J, Patel S, Curtis N. Biological profile of L-745,870, a selective antagonist with high affinity for the dopamine D4 receptor. Journal of Pharmacology and Experimental Therapeutics. 1997 Nov 1; 283(2):636-47.
De Freitas ES, Da Silva PB, Chorilli M, Batista AA, de Oliveira Lopes É, Silva MM, Leite CQ, Pavan FR. Nanostructured lipid systems as a strategy to improve the in vitro cytotoxicity of ruthenium (II) compounds. Molecules. 2014 May; 19(5):5999-6008. https://doi.org/10.3390/molecules19055999
Da Silva PB, de Freitas ES, Bernegossi J, Gonçalez ML, Sato MR, Leite CQ, Pavan FR, Chorilli M. Nanotechnology-based drug delivery systems for treatment of tuberculosis-a review. Journal of biomedical nanotechnology. 2016 Feb 1; 12(2):241-60. https://doi.org/10.1166/jbn.2016.2149
Pandey R, Khuller GK. Nanotechnology based drug delivery system (s) for the management of tuberculosis, Indian J Exp Biol, 2006 May; 44(5):357-66.
Nishiyama N, Kataoka K. Current state, achievements, and future prospects of polymeric micelles as nanocarriers for drug and gene delivery. Pharmacology & therapeutics. 2006 Dec 1; 112(3):630-48. https://doi.org/10.1016/j.pharmthera.2006.05.006
López-Donaire ML, Sussman EM, Fernández-Gutiérrez M, Méndez-Vilas A, Ratner BD, Vázquez-Lasa B, San Román J. Amphiphilic self-assembled "polymeric drugs": Morphology, properties, and biological behavior of nanoparticles. Biomacromolecules. 2012 Mar 12; 13(3):624-35. https://doi.org/10.1021/bm300043f
Zhang Y, Huang Y, Zhao W, Lu J, Zhang P, Zhang X, Li J, Gao X, Venkataramanan R, Li S. Fmoc-conjugated PEG-vitamin E 2 micelles for tumor-targeted delivery of paclitaxel: enhanced drug-carrier interaction and loading capacity. The AAPS journal. 2014 Nov; 16(6):1282-91. https://doi.org/10.1208/s12248-014-9651-2
Neves MM, González-García MB, Santos-Silva A, Costa-García A. Voltammetric immunosensor for the diagnosis of celiac disease based on the quantification of anti-gliadin antibodies. Sensors and Actuators B: Chemical. 2012 Mar 1; 163 (1):253-9. https://doi.org/10.1016/j.snb.2012.01.048
Freitag TL, Podojil JR, Pearson RM, Fokta FJ, Sahl C, Messing M, Andersson LC, Leskinen K, Saavalainen P, Hoover LI, Huang K. Gliadin nanoparticles induce immune tolerance to gliadin in mouse models of celiac disease. Gastroenterology. 2020 May 1; 158 (6):1667-81. https://doi.org/10.1053/j.gastro.2020.01.045
Shen L, Ciesielski M, Ramakrishnan S, Miles KM, Ellis L, Sotomayor P, Shrikant P, Fenstermaker R, Pili R. Class I histone deacetylase inhibitor entinostat suppresses regulatory T cells and enhances immunotherapies in renal and prostate cancer models. PloS one. 2012 Jan 27; 7(1):e30815. https://doi.org/10.1371/journal.pone.0030815
Wang YJ, Larsson M, Huang WT, Chiou SH, Nicholls SJ, Chao JI, Liu DM. The use of polymer-based nanoparticles and nanostructured materials in treatment and diagnosis of cardiovascular diseases: Recent advances and emerging designs. Progress in Polymer Science. 2016 Jun 1; 57:153-78. https://doi.org/10.1016/j.progpolymsci.2016.01.002
Deng Y, Zhang X, Shen H, He Q, Wu Z, Liao W, Yuan M. Application of the nano-drug delivery system in treatment of cardiovascular diseases. Frontiers in bioengineering and biotechnology. 2020 Jan 31; 7:489. https://doi.org/10.3389/fbioe.2019.00489
Agarwal H, Shanmugam VK. Synthesis and optimization of zinc oxide nanoparticles using Kalanchoe pinnata towards the evaluation of its anti-inflammatory activity. Journal of Drug Delivery Science and Technology. 2019 Dec 1; 54:101291. https://doi.org/10.1016/j.jddst.2019.101291
Aathira CM, Arivarasu L, Rajeshkumar S. Antioxidant and Anti-Inflammatory Potential of Chromium Picolinate Mediated Zinc Oxide Nanoparticle. Journal of Pharmaceutical Research International. 2020 Aug 26:118-21. https://doi.org/10.9734/jpri/2020/v32i1930717
Liu C, Chen Z, Ye Z, He D, Dang Y, Li Z, Wang L, Ren M, Fan Z, Liu H. Therapeutic Applications of Functional Nanomaterials for Prostatitis. Front. Pharmacol. 2021; 12: 685465. https://doi.org/10.3389/fphar.2021.685465
Published
Abstract Display: 739 
PDF Downloads: 749 PDF Downloads: 75 How to Cite
Issue
Section
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
.